Zum Inhalt springen
Mann·Vitalis

Transparenz

Quellen & Studien

Jede gesundheitsbezogene Aussage in unseren Artikeln ist an eine konkrete Studie gebunden. Diese Seite sammelt alle zitierten Arbeiten — 426 Quellen, davon 301 direkt zu PubMed verlinkt. Wie wir auswählen, steht auf der Seite Methodik.

  1. 20

    Aburto NJ et al. Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses. BMJ. 2013.

  2. 21

    Anothaisintawee T et al. Management of chronic prostatitis/chronic pelvic pain syndrome: a systematic review and network meta-analysis. JAMA. 2011.

  3. 23

    Camacho EM et al. Age-associated changes in hypothalamic-pituitary-testicular function in middle-aged and older men are modified by weight change and lifestyle factors (EMAS). Eur J Endocrinol. 2013.

  4. 25

    Europäische Kommission: EU-Register nährwert- und gesundheitsbezogener Angaben, Verordnung (EU) Nr. 432/2012 (Magnesium und normale Muskelfunktion, normale Funktion des Nervensystems, Verringerung von Müdigkeit und Ermüdung).

  5. 26

    Europäische Kommission: EU-Register nährwert- und gesundheitsbezogener Angaben, Verordnung (EU) Nr. 432/2012 (Vitamin B12 und Folat: Beitrag zu einem normalen Energiestoffwechsel, zur normalen Funktion des Nervensystems, zur normalen psychischen Funktion und zur Verringerung von Müdigkeit).

  6. 30

    Ilic D et al. Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis. BMJ. 2018.

  7. 31

    Kloppenburg M et al. 2018 update of the EULAR recommendations for the management of hand osteoarthritis. Ann Rheum Dis. 2019.

  8. 36

    Verdon F et al. Iron supplementation for unexplained fatigue in non-anaemic women: double blind randomised placebo controlled trial. BMJ. 2003.

  9. 37

    Abuelgasim H et al. Effectiveness of honey for symptomatic relief in upper respiratory tract infections: a systematic review and meta-analysis. BMJ Evid Based Med. 2021.

  10. 38

    Akhgarjand C et al. Does Ashwagandha supplementation have a beneficial effect on the management of anxiety and stress? A systematic review and meta-analysis of randomized controlled trials. Phytother Res. 2022.

  11. 39

    Anti M et al. Water supplementation enhances the effect of high-fiber diet on stool frequency and laxative consumption in adult patients with functional constipation. Hepatogastroenterology. 1998.

  12. 41

    Björnsson HK et al. Ashwagandha-induced liver injury: a case series from Iceland and the US Drug-Induced Liver Injury Network. Liver Int. 2020.

  13. 42

    Blancquaert L et al. Timeline (Bioavailability) of Magnesium Compounds in Hours: Which Magnesium Compound Works Best? Biol Trace Elem Res. 2019.

  14. 43

    Bolland MJ et al. Effects of vitamin D supplementation on musculoskeletal health: a systematic review, meta-analysis, and trial sequential analysis. Lancet Diabetes Endocrinol. 2018.

  15. 44

    Booth SL, Al Rajabi A. Bone health and osteoporosis: the role of vitamin K and potential antagonism by anticoagulants. Nutr Clin Pract. 2007.

  16. 45

    Boyle NB, Lawton C, Dye L. The effects of magnesium supplementation on subjective anxiety and stress — a systematic review. Nutrients. 2017.

  17. 46

    Brandani JZ et al. Device and non-device-guided slow breathing to reduce blood pressure: a systematic review and meta-analysis. Complement Ther Med. 2019.

  18. 48

    Bundesinstitut für Risikobewertung (BfR): Höchstmengenvorschläge für Magnesium in Nahrungsergänzungsmitteln, 2021.

  19. 49

    Chi CC et al. Interventions for prevention of herpes simplex labialis (cold sores on the lips). Cochrane Database Syst Rev. 2015.

  20. 50

    Christodoulides S et al. Systematic review with meta-analysis: effect of fibre supplementation on chronic idiopathic constipation in adults. Aliment Pharmacol Ther. 2016.

  21. 51

    Cooper TE et al. D-mannose for preventing and treating urinary tract infections. Cochrane Database Syst Rev. 2022.

  22. 52

    Cornelissen VA, Smart NA. Exercise training for blood pressure: a systematic review and meta-analysis. J Am Heart Assoc. 2013.

  23. 53

    Corona G et al. Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis. Eur J Endocrinol. 2013.

  24. 54

    Corona G et al. Testosterone supplementation and body composition: results from a meta-analysis of observational studies. J Endocrinol Invest. 2016.

  25. 55

    Cryer PE et al. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2009.

  26. 56

    Csikós E et al. / Review: What do we know about phytotherapy of benign prostatic hyperplasia? Life Sci. 2015.

  27. 57

    DiNicolantonio JJ et al. Vitamins K1 and K2: The Emerging Group of Vitamins Required for Human Health. J Nutr Metab. 2017.

  28. 58

    EAU Guidelines on Management of Non-Neurogenic Male LUTS, European Association of Urology.

  29. 59

    Europäische Arzneimittel-Agentur (EMA), Ausschuss für pflanzliche Arzneimittel (HMPC): Pflanzliche Monographien (traditional-use) zu Achillea millefolium, Angelica archangelica, Cynara scolymus und Silybum marianum.

  30. 60

    Europäische Kommission: EU-Register nährwert- und gesundheitsbezogener Angaben, Verordnung (EU) Nr. 432/2012 (Magnesium und normale Muskelfunktion, Elektrolytgleichgewicht).

  31. 61

    Europäische Kommission: EU-Register nährwert- und gesundheitsbezogener Angaben, Verordnung (EU) Nr. 432/2012 (Magnesium und normale Muskelfunktion).

  32. 62

    Fang X et al. Dietary magnesium intake and the risk of cardiovascular disease, type 2 diabetes, and all-cause mortality: a dose-response meta-analysis of prospective cohort studies. BMC Med. 2016.

  33. 63

    Fatemeh G et al. Does valerian work for insomnia? An umbrella review of the evidence. Eur Neuropsychopharmacol. 2024.

  34. 64

    Feller M et al. Levothyroxine treatment and clinical outcomes in older people with subclinical hypothyroidism: pooled individual results. 2021.

  35. 65

    FitzGerald MP, Anderson RU et al. Randomized multicenter feasibility trial of myofascial physical therapy for urological chronic pelvic pain syndromes. J Urol. 2013.

  36. 66

    Ford AC et al. American College of Gastroenterology Monograph on Management of Irritable Bowel Syndrome. Am J Gastroenterol. 2018.

  37. 67

    He FJ, Li J, MacGregor GA. Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev. 2013.

  38. 68

    Hemilä H et al. Zinc lozenges and the common cold: a meta-analysis comparing zinc acetate and zinc gluconate, and the role of zinc dosage. JRSM Open. 2017.

  39. 69

    Holtmann G et al. Efficacy of artichoke leaf extract in the treatment of patients with functional dyspepsia: a six-week placebo-controlled, double-blind, multicentre trial. Aliment Pharmacol Ther. 2003.

  40. 70

    Kaplan SA et al. Tolterodine and tamsulosin for treatment of men with LUTS and overactive bladder: a randomized controlled trial. JAMA. 2006.

  41. 71

    Knowler WC et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin (Diabetes Prevention Program). N Engl J Med. 2002.

  42. 72

    Kranjčec B et al. D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World J Urol. 2014.

  43. 73

    Lane R et al. Exercise for intermittent claudication. Cochrane Database Syst Rev. 2017.

  44. 74

    Leitlinienprogramm der DGU: S2e-Leitlinie Benignes Prostatasyndrom, aktuelle Fassung.

  45. 75

    Lepor H. Alpha-blockers for the Treatment of Benign Prostatic Hyperplasia. Urol Clin North Am. 2016.

  46. 76

    Lerner LB, McVary KT et al. Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline. J Urol. 2021.

  47. 77

    Lippman SM et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA. 2009.

  48. 78

    Neter JE et al. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension. 2003.

  49. 79

    Nickel JC et al. Alfuzosin and symptoms of chronic prostatitis-chronic pelvic pain syndrome. N Engl J Med. 2008.

  50. 80

    Nickel JC et al. Prevalence of prostatitis-like symptoms in a population based study using the NIH-CPSI. J Urol. 2001.

  51. 81

    Parsons JK, Kashefi C. Physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms. Eur Urol. 2008.

  52. 82

    Pittler MH, Ernst E. Horse chestnut seed extract for chronic venous insufficiency. Cochrane Database Syst Rev. 2012.

  53. 83

    Poorolajal J et al. Daily potassium intake and sodium-to-potassium ratio in the reduction of blood pressure: a meta-analysis of randomized controlled trials. J Hypertens. 2015.

  54. 85

    Rambaldi A et al. Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases. Cochrane Database Syst Rev. 2007.

  55. 86

    Ras RT et al. LDL-cholesterol-lowering effect of plant sterols and stanols across different dose ranges: a meta-analysis of randomised controlled studies. Br J Nutr. 2014.

  56. 87

    Reynolds A et al. Carbohydrate quality and human health: a series of systematic reviews and meta-analyses. Lancet. 2019.

  57. 88

    Roehrborn CG et al. The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic BPH (CombAT). Eur Urol. 2010.

  58. 89

    Rønn SH et al. The effect of vitamin MK-7 on bone mineral density and microarchitecture in postmenopausal women with osteopenia, a 3-year randomized, placebo-controlled clinical trial. Osteoporos Int. 2021.

  59. 90

    Shoskes DA et al. Clinical phenotyping of CP/CPPS and correlation with symptom severity (UPOINT). Urology. 2009.

  60. 92

    Slavin J. Fiber and prebiotics: mechanisms and health benefits. Nutrients. 2013. (Einordnung fermentierbarer Kohlenhydrate und Kulturen)

  61. 93

    Sperber AD et al. Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study. Gastroenterology. 2021. PMID 32294476.

  62. 94

    Zhang X et al. Effects of Magnesium Supplementation on Blood Pressure: A Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials. Hypertension. 2016.

  63. 95

    2023 ESH Guidelines for the management of arterial hypertension.

  64. 96

    A Comprehensive Overview of Subacute Combined Degeneration: MRI Diagnostic Challenges and Treatment Pathways. Brain Sci. 2025.

  65. 97

    Abbasi B et al. The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial. J Res Med Sci. 2012.

  66. 98

    Adalsteinsson JA et al. Seborrheic dermatitis — looking beyond Malassezia. Exp Dermatol. 2019.

  67. 99

    Adil A, Godwin M. The effectiveness of treatments for androgenetic alopecia: a systematic review and meta-analysis. J Am Acad Dermatol. 2017.

  68. 100

    Advances in Nutrition. Gastrointestinal Effects and Tolerance of Nondigestible Carbohydrate Consumption. Adv Nutr. 2022.

  69. 101

    Age-Related Eye Disease Study 2 (AREDS2) Research Group. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration. JAMA. 2013.

  70. 102

    Allen RW et al. Cinnamon use in type 2 diabetes: an updated systematic review and meta-analysis. Ann Fam Med. 2013.

  71. 103

    Allgemeine Ernährungsphysiologie: essenzielle Aminosäuren (DGE-Referenzwerte für die Nährstoffzufuhr).

  72. 104

    American College of Gastroenterology: Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease.

  73. 105

    Andreux PA et al. The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans. Nat Metab. 2019.

  74. 106

    Aroda VR et al. Long-term metformin use and vitamin B12 deficiency in the Diabetes Prevention Program Outcomes Study. J Clin Endocrinol Metab. 2016.

  75. 107

    Ashraf H, Boucher NL. The role of micronutrients in thyroid dysfunction. Sudan J Paediatr. 2020.

  76. 108

    Attaluri A et al. Randomised clinical trial: dried plums (prunes) vs. psyllium for constipation. Aliment Pharmacol Ther. 2011.

  77. 109

    AWMF S3-Leitlinie: Epidemiologie, Diagnostik, Therapie, Prävention und Management unkomplizierter, bakterieller, ambulant erworbener Harnwegsinfektionen bei erwachsenen Patienten.

  78. 110

    Baechle JJ et al. Chronic inflammation and the hallmarks of aging. Mol Metab. 2023.

  79. 111

    Barel A et al. Effect of oral intake of choline-stabilized orthosilicic acid on skin, nails and hair in women with photodamaged skin. Arch Dermatol Res. 2005.

  80. 112

    Barry MJ et al.: The American Urological Association symptom index for benign prostatic hyperplasia (IPSS). J Urol, 1992.

  81. 113

    Barry MJ et al.: The American Urological Association symptom index for BPH (IPSS). J Urol, 1992.

  82. 114

    Bashir Y et al. Effects of long-term oral magnesium chloride replacement in congestive heart failure secondary to coronary artery disease. Am J Cardiol. 1993.

  83. 115

    Beigrezaei S et al. The addition of exercise to a weight loss diet on inflammatory markers: a systematic review and meta-analysis of controlled clinical trials. Crit Rev Food Sci Nutr. 2023.

  84. 116

    Berufsverband der Augenärzte Deutschlands (BVA): Informationen zu Bildschirmarbeit und „Office Eye Syndrome“.

  85. 117

    Beyond Weight Loss: Skeletal Muscle Health During Incretin-Based Therapy in Patients with Diabesity. Nutrients. 2026.

  86. 118

    Bhasin S et al. Development of models to predict anabolic response to testosterone administration in healthy young men. Am J Physiol Endocrinol Metab. 2003.

  87. 119

    Bhasin S et al.: Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab, 2018.

  88. 120

    Bjelakovic G et al. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev. 2012.

  89. 121

    Blais JE et al. Overall and Sex-Specific Effect of Berberine for the Treatment of Dyslipidemia in Adults. Drugs. 2023.

  90. 122

    Blancquaert L et al.: Predicting and testing bioavailability of magnesium supplements. Nutrients, 2019.

  91. 123

    Bolland MJ et al. Calcium intake and risk of fracture: systematic review. BMJ. 2015.

  92. 124

    Bolland MJ et al. Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative. BMJ. 2011.

  93. 125

    Bonnema AL et al. Gastrointestinal tolerance of chicory inulin products. J Am Diet Assoc. 2010.

  94. 126

    Boonstra E et al. Neurotransmitters as food supplements: the effects of GABA on brain and behavior. Front Psychol. 2015.

  95. 127

    Borda LJ, Wikramanayake TC. Seborrheic dermatitis and dandruff: a comprehensive review. J Clin Investig Dermatol. 2015.

  96. 128

    British Dietetic Association. Guidelines for the Dietary Management of Chronic Constipation in Adults. J Hum Nutr Diet. 2025.

  97. 129

    Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) / Kommission E: Monographien zu Schafgarbenkraut, Angelikawurzel, Wermutkraut, Enzianwurzel.

  98. 130

    Cadegiani FA, Kater CE. Adrenal fatigue does not exist: a systematic review. BMC Endocr Disord. 2016.

  99. 131

    Carson CF et al. Melaleuca alternifolia (tea tree) oil gel (6%) for the treatment of recurrent herpes labialis. J Antimicrob Chemother. 2001.

  100. 132

    Chaddha A et al. Device and nondevice-guided slow breathing to reduce blood pressure in hypertensive patients: a systematic review and meta-analysis. Health Sci Rep. 2022.

  101. 133

    Cheah KL et al. Effect of Ashwagandha (Withania somnifera) extract on sleep: A systematic review and meta-analysis. PLoS One. 2021.

  102. 134

    Chen F et al. Efficacy and safety of nucleoside antiviral drugs for treatment of recurrent herpes labialis: a systematic review and meta-analysis. J Oral Pathol Med. 2017.

  103. 135

    Chiu HY et al. Effects of Intravenous and Oral Magnesium on Reducing Migraine: A Meta-analysis of Randomized Controlled Trials. Pain Physician. 2016.

  104. 136

    Cholesterol Treatment Trialists' (CTT) Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials. Lancet. 2010.

  105. 137

    Cholesterol Treatment Trialists' Collaboration. Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials. Lancet. 2019.

  106. 138

    Clegg DO et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med. 2006.

  107. 139

    Clemesha CG et al. 'Testosterone Boosting' Supplements Composition and Claims Are not Supported by the Academic Literature. World J Mens Health. 2020.

  108. 140

    Comparative effectiveness of treatment options for subacromial shoulder conditions: a systematic review. Ther Adv Musculoskelet Dis. 2021.

  109. 141

    Comprehensive Effects of Magnesium Supplementation on Cardiometabolic Risk Factors: A Systematic Review and Dose-Response Meta-Analysis. Nutrients. 2026.

  110. 142

    Corona G et al. Late-onset hypogonadism: metabolic impact. Andrology. 2020.

  111. 143

    Corona G et al. Testosterone supplementation and sexual function: a meta-analysis. J Sex Med. 2014.

  112. 144

    Corona G, Rastrelli G, Maggi M. Androgens and male sexual function. Best Pract Res Clin Endocrinol Metab. 2022.

  113. 145

    Daily JW et al. Efficacy of turmeric extracts and curcumin for alleviating the symptoms of joint arthritis: a systematic review and meta-analysis of randomized clinical trials. J Med Food. 2016.

  114. 146

    Daryanto B et al. Holmium laser enucleation of the prostate versus transurethral resection of the prostate. Curr Urol. 2025.

  115. 147

    de Ligny W et al. Antioxidants for male subfertility. Cochrane Database Syst Rev. 2022.

  116. 148

    de Miranda RB et al. Effects of hydrolyzed collagen supplementation on skin aging: a systematic review and meta-analysis. Int J Dermatol. 2021.

  117. 149

    Derry S et al. Topical NSAIDs for chronic musculoskeletal pain in adults. Cochrane Database Syst Rev. 2016.

  118. 150

    Deutsche Dermatologische Gesellschaft: Informationen zu Herpes simplex labialis (Lippenherpes).

  119. 151

    Deutsche Dermatologische Gesellschaft: S3-Leitlinie Androgenetische Alopezie.

  120. 152

    Deutsche Diabetes Gesellschaft (DDG): Praxisempfehlungen — Definition, Klassifikation und Diagnostik des Diabetes mellitus, aktuelle Fassung.

  121. 153

    Deutsche Diabetes Gesellschaft (DDG): Praxisempfehlungen — Definition, Klassifikation und Diagnostik, aktuelle Fassung.

  122. 154

    Deutsche Diabetes Gesellschaft (DDG): Praxisempfehlungen — Diagnostik und Differenzialdiagnose von Hypoglykämien, aktuelle Fassung.

  123. 155

    Deutsche Gesellschaft für Allgemeinmedizin (DEGAM): S3-Leitlinie Akuter und chronischer Husten.

  124. 156

    Deutsche Gesellschaft für Angiologie: S3-Leitlinie „Periphere arterielle Verschlusskrankheit (PAVK), Diagnostik, Therapie und Nachsorge“.

  125. 157

    Deutsche Gesellschaft für Angiologie: S3-Leitlinie „Periphere arterielle Verschlusskrankheit (PAVK)“.

  126. 158

    Deutsche Gesellschaft für Endokrinologie: Informationen zu Hyperthyreose und zu hormonaktiven Tumoren (Karzinoid, Phäochromozytom).

  127. 159

    Deutsche Gesellschaft für Endokrinologie: Informationen zum Cushing-Syndrom (Diagnostik: 24-h-Urin-Cortisol, Speichel-Cortisol spätabends, Dexamethason-Hemmtest).

  128. 160

    Deutsche Gesellschaft für Endokrinologie: Informationen zum Hypogonadismus des Mannes.

  129. 161

    Deutsche Gesellschaft für Endokrinologie: Leitlinie Diagnostik und Therapie der Hyperthyreose.

  130. 162

    Deutsche Gesellschaft für Ernährung (DGE): Referenzwerte für die Magnesiumzufuhr.

  131. 163

    Deutsche Gesellschaft für Ernährung (DGE): Referenzwerte für die Nährstoffzufuhr; Stellungnahmen zu Vitamin D, Jod, Folat.

  132. 164

    Deutsche Gesellschaft für Ernährung (DGE): Referenzwerte für die Zufuhr von Folat (300 µg Folat-Äquivalent/Tag für Erwachsene); EFSA: Tolerable Upper Intake Level 1.000 µg/Tag für synthetische Folsäure.

  133. 165

    Deutsche Gesellschaft für Ernährung (DGE): Referenzwerte für die Zufuhr von Vitamin B12 (Schätzwert 4 µg/Tag für Erwachsene).

  134. 166

    Deutsche Gesellschaft für Ernährung (DGE): Referenzwerte für die Zufuhr von Vitamin E (Schätzwert ~14 mg/Tag für Männer).

  135. 167

    Deutsche Gesellschaft für Ernährung (DGE): Referenzwerte Magnesium.

  136. 168

    Deutsche Gesellschaft für Ernährungsmedizin (DGEM): Leitlinie Klinische Ernährung (Aminosäuren, Glutamin bei kritisch Kranken).

  137. 169

    Deutsche Gesellschaft für Gastroenterologie (DGVS): S2k-Leitlinie Chronische Obstipation.

  138. 170

    Deutsche Gesellschaft für Gastroenterologie (DGVS): S2k-Leitlinie Gastroösophageale Refluxkrankheit.

  139. 171

    Deutsche Gesellschaft für Gastroenterologie (DGVS): S2k-Leitlinie Nicht-alkoholische Fettlebererkrankung.

  140. 172

    Deutsche Gesellschaft für Neurologie (DGN) / DGPPN: S3-Leitlinie Demenzen.

  141. 173

    Deutsche Gesellschaft für Phlebologie und Lymphologie: Leitlinien zu Varikose und Kompressionstherapie.

  142. 174

    Deutsche Gesellschaft für Phlebologie und Lymphologie: Medizinische Kompressionstherapie (S1-/S2k-Leitlinien).

  143. 175

    Deutsche Gesellschaft für Phlebologie und Lymphologie: S2k-Leitlinie Diagnostik und Therapie der Varikose sowie Leitlinie Medizinische Kompressionstherapie.

  144. 176

    Deutsche Gesellschaft für Schlafforschung und Schlafmedizin (DGSM): S3-Leitlinie Nicht erholsamer Schlaf / Schlafstörungen — Insomnie bei Erwachsenen.

  145. 177

    Deutsche Ophthalmologische Gesellschaft (DOG) / Berufsverband der Augenärzte: Informationen zur nutritiv-toxischen Optikusneuropathie (Tabak-Alkohol-Amblyopie, Vitamin-B12-Mangel).

  146. 178

    DiNicolantonio JJ, O'Keefe JH, Wilson W. Subclinical magnesium deficiency: a principal driver of cardiovascular disease and a public health crisis. Open Heart. 2018.

  147. 179

    Dong H et al. Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis. Evid Based Complement Alternat Med. 2012.

  148. 180

    Dong JY et al. Effect of oral L-arginine supplementation on blood pressure: a meta-analysis of randomized, double-blind, placebo-controlled trials. Am Heart J. 2011.

  149. 181

    Dorey G, Speakman M et al. Pelvic floor exercises for treating post-micturition dribble in men with erectile dysfunction: a randomised controlled trial. Urol Nurs. 2004.

  150. 182

    Dorey G. Restoring pelvic floor function in men: review of randomised controlled trials. Br J Nurs. 2005.

  151. 183

    Drossman DA, Hasler WL. Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features and Rome IV. Gastroenterology. 2016.

  152. 184

    Dry Eye Assessment and Management Study Research Group. n-3 Fatty Acid Supplementation for the Treatment of Dry Eye Disease. N Engl J Med. 2018.

  153. 185

    EAU Guidelines on Sexual and Reproductive Health — Male Hypogonadism, European Association of Urology.

  154. 186

    EFSA / Scientific Committee on Food: Tolerable Upper Intake Level für Magnesium aus Nahrungsergänzung: 250 mg/Tag. Europäische Kommission: EU-Register, Verordnung (EU) Nr. 432/2012.

  155. 187

    EFSA: Scientific Opinion on beta-glucans and reduction of post-prandial glycaemic responses, 2011.

  156. 188

    EFSA: Scientific Opinion on Dietary Reference Values for zinc (2014) und Tolerable Upper Intake Level 25 mg/Tag für Erwachsene.

  157. 189

    EFSA: Tolerable Upper Intake Level für Selen 255–300 µg/Tag für Erwachsene; DGE-Referenzwert 60–70 µg/Tag.

  158. 190

    EFSA: Tolerable Upper Intake Level für zusätzliches Magnesium aus Präparaten 250 mg/Tag (abführende Wirkung als begrenzender Faktor).

  159. 191

    Elahi Vahed I et al. The effect of berberine on obesity indices: a systematic review and meta-analysis. Int J Obes (Lond). 2026.

  160. 192

    EMA / EU-Verordnung 2022/860: Höchstmenge für Monacoline aus rotem Reis in Lebensmitteln.

  161. 193

    EMA/HMPC: Community herbal monograph on Urtica dioica L., radix und Urtica dioica L./Urtica urens L., folium (traditional use).

  162. 194

    EU-Register nährwert- und gesundheitsbezogener Angaben (kein zugelassener Health Claim für Artischocke, Mariendistel oder Schafgarbe).

  163. 195

    EU-Register nährwert- und gesundheitsbezogener Angaben (kein zugelassener Health Claim für D-Mannose).

  164. 196

    EU-Register nährwert- und gesundheitsbezogener Angaben (kein zugelassener Health Claim für Kürbiskern bei Prostata oder Blase; zulässig ist die Zink-Aussage).

  165. 197

    EU-Register nährwert- und gesundheitsbezogener Angaben (kein zugelassener Health Claim für Lysin, Melisse oder Teebaumöl bei Herpes).

  166. 198

    EU-Register nährwert- und gesundheitsbezogener Angaben (keine zugelassene Angabe zu Nahrungsergänzung bei „Wechseljahren des Mannes“).

  167. 199

    EU-Register nährwert- und gesundheitsbezogener Angaben (keine zugelassene Angabe zu Nahrungsergänzung bei Kopfhautschuppen; Biotin-Claim betrifft „normale Haut“, nicht Schuppen).

  168. 200

    EU-Register nährwert- und gesundheitsbezogener Angaben, Verordnung (EU) Nr. 432/2012 — keine zugelassene Angabe für Kefir oder „probiotische“ Lebensmittel; zulässig sind Nährstoffaussagen zu Calcium, Eiweiß, B12, Riboflavin.

  169. 201

    EU-Register nährwert- und gesundheitsbezogener Angaben, Verordnung (EU) Nr. 432/2012 (B-Vitamine, Calcium).

  170. 202

    EU-Register nährwert- und gesundheitsbezogener Angaben, Verordnung (EU) Nr. 432/2012 (Ballaststoffe und normale Darmfunktion).

  171. 203

    EU-Register nährwert- und gesundheitsbezogener Angaben, Verordnung (EU) Nr. 432/2012 (Ballaststoffe, Beitrag zu einer normalen Darmfunktion).

  172. 204

    EU-Register nährwert- und gesundheitsbezogener Angaben, Verordnung (EU) Nr. 432/2012 (Beta-Glucane und die Aufrechterhaltung eines normalen Cholesterinspiegels; 3 g/Tag).

  173. 205

    EU-Register nährwert- und gesundheitsbezogener Angaben, Verordnung (EU) Nr. 432/2012 (Beta-Glucane und die Aufrechterhaltung eines normalen Cholesterinspiegels).

  174. 206

    EU-Register nährwert- und gesundheitsbezogener Angaben, Verordnung (EU) Nr. 432/2012 (Biotin, Zink, Selen und die Erhaltung normaler Haare).

  175. 207

    EU-Register nährwert- und gesundheitsbezogener Angaben, Verordnung (EU) Nr. 432/2012 (Cholin und normale Leberfunktion).

  176. 208

    EU-Register nährwert- und gesundheitsbezogener Angaben, Verordnung (EU) Nr. 432/2012 (Chrom und die Aufrechterhaltung eines normalen Blutzuckerspiegels; keine Krankheitsbezug-Angaben).

  177. 209

    EU-Register nährwert- und gesundheitsbezogener Angaben, Verordnung (EU) Nr. 432/2012 (der Schutz der Zellen vor oxidativem Stress ist für Vitamin C, E, Selen, Zink, Kupfer, Mangan und Riboflavin zugelassen, nicht für Coenzym Q10).

  178. 210

    EU-Register nährwert- und gesundheitsbezogener Angaben, Verordnung (EU) Nr. 432/2012 (kein Eintrag für die genannten Bitterpflanzen).

  179. 211

    EU-Register nährwert- und gesundheitsbezogener Angaben, Verordnung (EU) Nr. 432/2012 (kein spezifischer Claim für Inulin; allgemeine Ballaststoff-Aussage zur Darmfunktion).

  180. 212

    EU-Register nährwert- und gesundheitsbezogener Angaben, Verordnung (EU) Nr. 432/2012 (keine zugelassene Angabe zu Nahrungsergänzung bei Bursitis).

  181. 213

    EU-Register nährwert- und gesundheitsbezogener Angaben, Verordnung (EU) Nr. 432/2012 (Magnesium und die normale Funktion des Nervensystems).

  182. 214

    EU-Register nährwert- und gesundheitsbezogener Angaben, Verordnung (EU) Nr. 432/2012 (Magnesium: normale Muskel- und Nervenfunktion, normaler Energiestoffwechsel, Verringerung von Müdigkeit) — gilt für alle Magnesiumverbindungen.

  183. 215

    EU-Register nährwert- und gesundheitsbezogener Angaben, Verordnung (EU) Nr. 432/2012 (Vitamin A und Zink: Erhaltung normaler Sehkraft).

  184. 216

    EU-Register nährwert- und gesundheitsbezogener Angaben, Verordnung (EU) Nr. 432/2012 (Vitamin C und die normale Kollagenbildung für Haut, Knochen, Knorpel; für Kollagen selbst besteht keine zugelassene Angabe).

  185. 217

    EU-Register nährwert- und gesundheitsbezogener Angaben, Verordnung (EU) Nr. 432/2012 (Vitamin C, Kupfer, Mangan, Thiamin).

  186. 218

    EU-Register nährwert- und gesundheitsbezogener Angaben, Verordnung (EU) Nr. 432/2012 (Vitamin C, Zink, Selen, Vitamin D und die normale Funktion des Immunsystems).

  187. 219

    EU-Register nährwert- und gesundheitsbezogener Angaben, Verordnung (EU) Nr. 432/2012 (Vitamin D und K: Erhaltung normaler Knochen; Vitamin D: Muskelfunktion, Calciumaufnahme).

  188. 220

    EU-Register nährwert- und gesundheitsbezogener Angaben, Verordnung (EU) Nr. 432/2012 (Vitamin D und K: Erhaltung normaler Knochen).

  189. 221

    EU-Register nährwert- und gesundheitsbezogener Angaben, Verordnung (EU) Nr. 432/2012 (Zink: normale Funktion des Immunsystems, Erhalt eines normalen Testosteronspiegels).

  190. 222

    EU-Register nährwert- und gesundheitsbezogener Angaben, Verordnung (EU) Nr. 432/2012 (zulässig sind nur Nährstoffaussagen; keine Angaben zu „Detox“, „Booster“ oder Krankheitsvorbeugung).

  191. 223

    EU-Register nährwert- und gesundheitsbezogener Angaben, Verordnung (EU) Nr. 432/2012.

  192. 224

    EU-Register nährwert- und gesundheitsbezogener Angaben: für Ashwagandha (Withania somnifera) ist keine gesundheitsbezogene Angabe zugelassen.

  193. 225

    EU-Register nährwert- und gesundheitsbezogener Angaben: für GABA und L-Theanin ist keine gesundheitsbezogene Angabe zugelassen.

  194. 226

    EU-Register nährwert- und gesundheitsbezogener Angaben: für Probiotika ist keine gesundheitsbezogene Angabe zugelassen.

  195. 227

    Europäische Kommission: EU-Register nährwert- und gesundheitsbezogener Angaben, Verordnung (EU) Nr. 432/2012 (Beta-Glucane und postprandialer Blutzuckeranstieg; Chrom und normaler Blutzuckerspiegel).

  196. 228

    Europäische Kommission: EU-Register nährwert- und gesundheitsbezogener Angaben, Verordnung (EU) Nr. 432/2012 (Calcium, Vitamin D, Vitamin K, Zink, Magnesium und die Erhaltung normaler Knochen).

  197. 229

    Europäische Kommission: EU-Register nährwert- und gesundheitsbezogener Angaben, Verordnung (EU) Nr. 432/2012 (Kalium und die Aufrechterhaltung eines normalen Blutdrucks).

  198. 230

    Europäische Kommission: EU-Register nährwert- und gesundheitsbezogener Angaben, Verordnung (EU) Nr. 432/2012 (Magnesium und normale Funktion des Nervensystems, normale psychische Funktion, Verringerung von Müdigkeit und Ermüdung).

  199. 231

    Europäische Kommission: EU-Register nährwert- und gesundheitsbezogener Angaben, Verordnung (EU) Nr. 432/2012 (Magnesium und normale Funktion des Nervensystems).

  200. 232

    Europäische Kommission: EU-Register nährwert- und gesundheitsbezogener Angaben, Verordnung (EU) Nr. 432/2012 (Magnesium und normale Muskel- bzw. Nervenfunktion).

  201. 233

    Europäische Kommission: EU-Register nährwert- und gesundheitsbezogener Angaben, Verordnung (EU) Nr. 432/2012 (Magnesium und normale Muskelfunktion, normale Funktion des Nervensystems).

  202. 234

    Europäische Kommission: EU-Register nährwert- und gesundheitsbezogener Angaben, Verordnung (EU) Nr. 432/2012 (Magnesium und normale psychische bzw. Nervenfunktion).

  203. 235

    Europäische Kommission: EU-Register nährwert- und gesundheitsbezogener Angaben, Verordnung (EU) Nr. 432/2012 (Magnesium und normaler Energiestoffwechsel, Verringerung von Müdigkeit und Ermüdung).

  204. 236

    Europäische Kommission: EU-Register nährwert- und gesundheitsbezogener Angaben, Verordnung (EU) Nr. 432/2012 (Zink und normaler Testosteronspiegel im Blut).

  205. 237

    European Association of Urology (EAU): Guidelines on Non-neurogenic Male LUTS.

  206. 238

    European Association of Urology (EAU): Guidelines on the Management of Non-neurogenic Male Lower Urinary Tract Symptoms (LUTS).

  207. 239

    European Association of Urology (EAU): Guidelines on Urological Infections.

  208. 240

    European Society of Cardiology (ESC): Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases.

  209. 241

    European Society of Cardiology / European Society of Hypertension: 2023 ESH Guidelines for the management of arterial hypertension.

  210. 242

    Evert AB et al. Nutrition Therapy for Adults With Diabetes or Prediabetes: A Consensus Report. Diabetes Care. 2019.

  211. 243

    Fach- und Gebrauchsinformationen zu Pantoprazol/Omeprazol; Deutsche Gesellschaft für Gastroenterologie (DGVS): S2k-Leitlinie Gastroösophageale Refluxkrankheit.

  212. 244

    Fachinformationen Phenprocoumon (Marcumar) und der direkten oralen Antikoagulanzien: Angaben zu Wechselwirkungen mit Vitamin K.

  213. 245

    Falco CN et al. Successful improvement of frequency and symptoms of premature complexes after oral magnesium administration. Arq Bras Cardiol. 2012.

  214. 246

    Fallah A et al. The Role of Zinc in Male Fertility. Int J Mol Sci. 2020.

  215. 247

    Fallik D et al. Iberogast-Induced Acute Liver Injury — A Case Report. Gastro Hep Adv. 2022.

  216. 248

    Fang S et al. Efficacy and safety of berberine in preventing recurrence of colorectal adenomas. J Ethnopharmacol. 2022.

  217. 249

    Farrell B et al. Deprescribing proton pump inhibitors: evidence-based clinical practice guideline. Can Fam Physician. 2017.

  218. 250

    Feldman HA et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts Male Aging Study. J Clin Endocrinol Metab. 2002.

  219. 251

    Ferracioli-Oda E et al. Meta-analysis: melatonin for the treatment of primary sleep disorders. PLoS One. 2013.

  220. 252

    Ferrucci L, Fabbri E. Inflammaging: a new immune-metabolic viewpoint for age-related diseases. Nat Rev Endocrinol. 2018.

  221. 253

    Field MS, Stover PJ. Safety of folic acid. Ann N Y Acad Sci. 2018.

  222. 254

    Filippini T et al. Potassium intake and blood pressure: a dose-response meta-analysis of randomized controlled trials. J Am Heart Assoc. 2020.

  223. 255

    Firoz M, Graber M. Bioavailability of US commercial magnesium preparations. Magnes Res. 2001.

  224. 256

    Ford AC et al. Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome. Aliment Pharmacol Ther. 2018.

  225. 257

    Foster HE, Barry MJ et al. Surgical Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline. J Urol. 2018.

  226. 258

    Franco JV et al. Non-pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome. Cochrane Database Syst Rev. 2018.

  227. 259

    Franco JV et al. Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome. Cochrane Database Syst Rev. 2019.

  228. 260

    Freedberg DE et al. The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the AGA. Gastroenterology. 2017.

  229. 261

    Gacci M et al. A systematic review and meta-analysis on the use of phosphodiesterase 5 inhibitors alone or in combination with alpha-blockers for LUTS due to BPH. Eur Urol. 2012.

  230. 262

    Garrison SR et al.: Magnesium for skeletal muscle cramps. Cochrane Database Syst Rev, 2020.

  231. 263

    Ghorbanibirgani A et al. The efficacy of stinging nettle (Urtica dioica) in patients with benign prostatic hyperplasia: a randomized double-blind study. Iran Red Crescent Med J. 2013.

  232. 264

    Gibb RD et al. Psyllium fiber improves glycemic control proportional to loss of glycemic control: a meta-analysis. Am J Clin Nutr. 2015.

  233. 265

    Gilling P et al. Three-year outcomes after Aquablation therapy compared to TURP: a blinded randomised trial. Can J Urol. 2020.

  234. 266

    Glazener C et al. Conservative treatment for urinary incontinence in Men After Prostate Surgery (MAPS): randomised controlled trials. Health Technol Assess. 2011.

  235. 267

    Guallar E et al. Enough is enough: stop wasting money on vitamin and mineral supplements. Ann Intern Med. 2013.

  236. 268

    Guan L, Miao P. The effects of taurine supplementation on obesity, blood pressure and lipid profile: A meta-analysis of randomized controlled trials. Eur J Pharmacol. 2020.

  237. 269

    Harman SM et al. Longitudinal effects of aging on serum total and free testosterone levels in healthy men (BLSA). J Clin Endocrinol Metab. 2001.

  238. 270

    Hashim H, Abrams P. How should patients with an overactive bladder manipulate their fluid intake? BJU Int. 2008.

  239. 271

    Hawkins J et al. Black elderberry (Sambucus nigra) supplementation effectively treats upper respiratory symptoms: a meta-analysis. Complement Ther Med. 2019.

  240. 272

    Hemilä H. Zinc lozenges may shorten the duration of colds: a systematic review. Open Respir Med J. 2011.

  241. 273

    Hertzler SR, Clancy SM. Kefir improves lactose digestion and tolerance in adults with lactose maldigestion. J Am Diet Assoc. 2003.

  242. 274

    Higgins JP et al. Energy Drinks and Their Impact on the Cardiovascular System: Potential Mechanisms. Adv Nutr. 2016.

  243. 275

    Hussain A, Saeed A. Hazardous or Advantageous: Uncovering the Roles of Heavy Metals and Humic Substances in Shilajit. Biol Trace Elem Res. 2024.

  244. 276

    Ichihara K et al. Tamsulosin monotherapy and its combination with mirabegron for overactive bladder induced by benign prostatic obstruction: a randomized controlled study. J Urol. 2015.

  245. 277

    Ilic D, Misso M. Lycopene for the prevention and treatment of benign prostatic hyperplasia and prostate cancer: a systematic review. Maturitas. 2012.

  246. 278

    IQWiG / Gesundheitsinformation.de: Gutartige Prostatavergrößerung.

  247. 279

    IQWiG / Gesundheitsinformation.de: Probleme beim Wasserlassen; Prostataentzündung.

  248. 280

    Irwin MR et al. Sleep Disturbance, Sleep Duration, and Inflammation: A Systematic Review and Meta-Analysis. Biol Psychiatry. 2016.

  249. 281

    Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022.

  250. 282

    Jefferson T et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev. 2014.

  251. 283

    Karsch-Völk M et al. Echinacea for preventing and treating the common cold. Cochrane Database Syst Rev. 2014.

  252. 284

    Kass L, Weekes J, Carpenter L. Effect of magnesium supplementation on blood pressure: a meta-analysis. Eur J Clin Nutr. 2012.

  253. 285

    Kawai T et al. Adipose tissue inflammation and metabolic dysfunction in obesity. Am J Physiol Cell Physiol. 2021.

  254. 286

    Kelgane SB et al. Clinical evaluation of the pharmacological impact of ashwagandha root extract on sleep in healthy volunteers and insomnia patients. J Ethnopharmacol. 2021.

  255. 287

    Keller JL et al. The effects of Shilajit supplementation on fatigue-induced decreases in muscular strength and serum hydroxyproline levels. J Int Soc Sports Nutr. 2019.

  256. 288

    Khanna R et al. Peppermint oil for the treatment of irritable bowel syndrome: a systematic review and meta-analysis. J Clin Gastroenterol. 2014.

  257. 289

    King D et al. Saline nasal irrigation for acute upper respiratory tract infections. Cochrane Database Syst Rev. 2015.

  258. 290

    Knowler WC et al. (Diabetes Prevention Program Research Group): N Engl J Med, 2002.

  259. 291

    Kommission E (BfArM/BGA): Monographie Equiseti herba (Schachtelhalmkraut).

  260. 292

    Koytchev R et al. Balm mint extract (Lo-701) for topical treatment of recurring herpes labialis. Phytomedicine. 1999.

  261. 293

    Lak M et al. Does creatine cause hair loss? A 12-week randomized controlled trial. J Int Soc Sports Nutr. 2025.

  262. 294

    Lam JR et al. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA. 2013.

  263. 295

    Langan RC, Goodbred AJ. Vitamin B12 Deficiency: Recognition and Management. Am Fam Physician. 2017.

  264. 296

    Leitlinienprogramm der DGU: S2e-Leitlinie Benignes Prostatasyndrom (BPS), aktuelle Fassung.

  265. 297

    Leitlinienprogramm Onkologie (AWMF): S3-Leitlinie Prostatakarzinom — Nebenwirkungen der Androgendeprivation, Management von Hitzewallungen.

  266. 298

    Lenger SM et al. D-mannose vs other agents for recurrent urinary tract infection prevention in adult women: a systematic review and meta-analysis. Am J Obstet Gynecol. 2020.

  267. 299

    Leproult R, Van Cauter E. Effect of 1 week of sleep restriction on testosterone levels in young healthy men. JAMA. 2011.

  268. 300

    Levine H et al. Temporal trends in sperm count: a systematic review and meta-regression analysis of samples collected globally in the 20th and 21st centuries. Hum Reprod Update. 2023.

  269. 301

    Liao B et al. Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners. J Int Soc Sports Nutr. 2021.

  270. 302

    Lincoff AM et al. Cardiovascular Safety of Testosterone-Replacement Therapy (TRAVERSE). N Engl J Med. 2023.

  271. 303

    Lincoff AM et al.: Cardiovascular Safety of Testosterone-Replacement Therapy (TRAVERSE). N Engl J Med, 2023.

  272. 304

    Litwin MS et al. The NIH Chronic Prostatitis Symptom Index: development and validation of a new outcome measure. J Urol. 1999.

  273. 305

    Longobardi I et al. Is It Time for a Requiem for Creatine Supplementation-Induced Kidney Failure? A Narrative Review. Nutrients. 2023.

  274. 306

    Ludwig DS et al. High glycemic index foods, overeating, and obesity. Pediatrics. 1999.

  275. 307

    MacFarquhar JK et al. Acute selenium toxicity associated with a dietary supplement. Arch Intern Med. 2010.

  276. 308

    Magistro G, Chapple CR et al. Emerging Minimally Invasive Treatment Options for Male Lower Urinary Tract Symptoms. Eur Urol. 2017.

  277. 309

    Mailoo VJ, Rampes S. Lysine for Herpes Simplex Prophylaxis: A Review of the Evidence. Integr Med (Encinitas). 2017.

  278. 310

    Martí-Carvajal AJ et al. Homocysteine-lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev. 2017.

  279. 311

    Martineau AR et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017.

  280. 312

    Max Rubner-Institut: Nationale Verzehrsstudie II (NVS II) — Nährstoffzufuhr der Bevölkerung in Deutschland.

  281. 313

    Mayr HL et al. Mediterranean-type diets and inflammatory markers in patients with coronary heart disease: a systematic review and meta-analysis. Nutr Res. 2018.

  282. 314

    McVary KT et al. Minimally Invasive Prostate Convective Water Vapor Energy Ablation (Rezūm): a multicenter, randomized controlled study. J Urol. 2016.

  283. 315

    Mellor R et al. Education plus exercise versus corticosteroid injection use versus a wait and see approach on global outcome and pain from gluteal tendinopathy: prospective, single blinded, randomised clinical trial (LEAP). BMJ. 2018.

  284. 316

    Messier SP et al. Effects of intensive diet and exercise on knee joint loads, inflammation, and clinical outcomes among overweight and obese adults with knee osteoarthritis: the IDEA randomized clinical trial. JAMA. 2013.

  285. 317

    Messina M et al. Neither soyfoods nor isoflavones warrant classification as endocrine disruptors: a technical review of the observational and clinical data. Crit Rev Food Sci Nutr. 2022.

  286. 318

    Micka A et al. Effect of consumption of chicory inulin on bowel function in healthy subjects with constipation: a randomized, double-blind, placebo-controlled trial. Int J Food Sci Nutr. 2017.

  287. 319

    Miller ER et al. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005.

  288. 320

    Mohamadi A et al. Corticosteroid injections give small and transient pain relief in rotator cuff tendinosis: a meta-analysis. Clin Orthop Relat Res. 2017.

  289. 321

    Monnier L et al. Magnitude of the dawn phenomenon and its impact on the overall glucose exposure in type 2 diabetes. Diabetes Care. 2013.

  290. 322

    Monnier L et al. The dawn phenomenon in type 2 diabetes: how to assess it in clinical practice? Diabetes Metab. 2015.

  291. 323

    Morishita D et al. Senna Versus Magnesium Oxide for the Treatment of Chronic Constipation: A Randomized, Placebo-Controlled Trial. Am J Gastroenterol. 2021.

  292. 324

    Mortensen SA et al. The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO. JACC Heart Fail. 2014.

  293. 325

    Nazari A et al. The Effect of Berberine Supplementation on Glycemic Control and Inflammatory Biomarkers in Metabolic Disorders: An Umbrella Meta-analysis. Clin Ther. 2024.

  294. 326

    O'Neal WT et al. Serum magnesium and burden of atrial and ventricular arrhythmias: The Atherosclerosis Risk in Communities (ARIC) Study. J Electrocardiol. 2020.

  295. 327

    OARSI / NICE: Leitlinien zur nicht-operativen Behandlung der Arthrose (Kollagen nicht empfohlen).

  296. 328

    Oduwole O et al. Honey for acute cough in children. Cochrane Database Syst Rev. 2018.

  297. 329

    Oelke M, Roehrborn CG et al. Nocturia improvement in the combination of Avodart and tamsulosin (CombAT) study. World J Urol. 2014.

  298. 330

    Oettlé GJ. Effect of moderate exercise on bowel habit. Gut. 1991.

  299. 331

    Page AT et al. The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis. Br J Clin Pharmacol. 2016.

  300. 332

    Pandit S et al. Clinical evaluation of purified Shilajit on testosterone levels in healthy volunteers. Andrologia. 2016.

  301. 333

    Pantoflickova D et al. Favourable effect of regular intake of fermented milk containing Lactobacillus johnsonii on Helicobacter pylori associated gastritis. Aliment Pharmacol Ther. 2003.

  302. 334

    Parsons JK, Im R. Alcohol consumption is associated with a decreased risk of benign prostatic hyperplasia. J Urol. 2009.

  303. 335

    Patel DP et al. A Review of the Use of Biotin for Hair Loss. Skin Appendage Disord. 2017.

  304. 336

    Pawlak R et al. How prevalent is vitamin B12 deficiency among vegetarians? Nutr Rev. 2013.

  305. 337

    Personalized treatment pathways for adult osteomalacia. J Clin Densitom. 2026.

  306. 338

    Philips CA et al. Ashwagandha-induced liver injury — a case series from India and literature review. Hepatol Commun. 2023.

  307. 339

    Pilz S et al. Effect of vitamin D supplementation on testosterone levels in men. Horm Metab Res. 2011.

  308. 340

    Pittler MH et al. Hawthorn extract for treating chronic heart failure. Cochrane Database Syst Rev. 2008.

  309. 341

    Post RE et al. Dietary fiber for the treatment of type 2 diabetes mellitus: a meta-analysis. J Am Board Fam Med. 2012.

  310. 342

    Pratte MA et al. An alternative treatment for anxiety: a systematic review of human trial results reported for the Ayurvedic herb ashwagandha (Withania somnifera). J Altern Complement Med. 2014.

  311. 343

    PRISCUS-Liste (potenziell inadäquate Medikation für ältere Menschen in Deutschland); DEGAM-Leitlinie Multimedikation.

  312. 344

    Qu H et al. Effect of Coenzyme Q10 on statin-associated myalgia and adherence to statin therapy: a systematic review and meta-analysis. Atherosclerosis. 2020.

  313. 345

    Qu W et al. Berberine alters the gut microbiota metabolism and impairs spermatogenesis. Acta Biochim Biophys Sin (Shanghai). 2024.

  314. 346

    Rabenberg M et al. Implications of standardization of serum 25-hydroxyvitamin D data for the evaluation of vitamin D status in Germany. BMC Public Health. 2018.

  315. 347

    Reimer C et al. Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy. Gastroenterology. 2009.

  316. 348

    Reynolds AN et al. Advice to walk after meals is more effective for lowering postprandial glycaemia in type 2 diabetes mellitus than advice that does not specify timing: a randomised crossover study. Diabetologia. 2016.

  317. 349

    Ridker PM et al. Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women. N Engl J Med. 2024.

  318. 350

    Robert G et al. Inflammation in benign prostatic hyperplasia: a 282 patients' immunohistochemical analysis. Prostate. 2009.

  319. 351

    Rohrmann S et al. Association of cigarette smoking, alcohol consumption and physical activity with lower urinary tract symptoms in older American men (NHANES III). BJU Int. 2005.

  320. 352

    Rohrmann S et al. Fruit and vegetable consumption, intake of micronutrients, and benign prostatic hyperplasia in US men. Am J Clin Nutr. 2007.

  321. 353

    Ross AC et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011.

  322. 354

    Rossi A et al. Progression of hair loss in men with androgenetic alopecia (male pattern hair loss): long-term (5-year) controlled study. Eur J Dermatol. 2008.

  323. 355

    Rubino D et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA. 2021.

  324. 356

    S3-Leitlinie Behandlung von Angststörungen (AWMF), aktuelle Fassung.

  325. 357

    S3-Leitlinie Epidemiologie, Diagnostik, Therapie … unkomplizierte Harnwegsinfektionen (AWMF).

  326. 358

    Safety issues of tirzepatide (pancreatitis and gallbladder or biliary disease) in type 2 diabetes and obesity. Front Endocrinol (Lausanne). 2023.

  327. 359

    Sahebkar A et al. Effects of pomegranate juice on blood pressure: a systematic review and meta-analysis of randomized controlled trials. Pharmacol Res. 2017.

  328. 360

    Sanda MG et al. Genetic susceptibility of benign prostatic hyperplasia. J Urol. 1994.

  329. 361

    Schwarz C et al. Effects of Spermidine Supplementation on Cognition and Biomarkers in Older Adults With Subjective Cognitive Decline: A Randomized Clinical Trial. JAMA Netw Open. 2022.

  330. 362

    Schwellnus MP. Cause of exercise associated muscle cramps (EAMC) — altered neuromuscular control, dehydration or electrolyte depletion? Br J Sports Med. 2009.

  331. 363

    Schwingshackl L et al. Effects of oils and solid fats on blood lipids: a systematic review and network meta-analysis. J Lipid Res. 2018.

  332. 364

    Scott IA et al. Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Intern Med. 2015.

  333. 365

    Senekowitsch S et al. High-Dose Spermidine Supplementation Does Not Increase Spermidine Levels in Blood Plasma and Saliva of Healthy Adults. Nutrients. 2023.

  334. 366

    Sesso HD et al. Multivitamins in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA. 2012.

  335. 367

    Shishehbor F et al. Vinegar consumption can attenuate postprandial glucose and insulin responses; a systematic review and meta-analysis. Diabetes Res Clin Pract. 2017.

  336. 368

    Shoskes DA et al. Quercetin in men with category III chronic prostatitis: a double-blind, placebo-controlled trial. Urology. 1999.

  337. 369

    Singh A et al. Urolithin A improves muscle strength, exercise performance, and biomarkers of mitochondrial health in a randomized trial in middle-aged adults. Cell Rep Med. 2022.

  338. 370

    Singh JA et al. Chondroitin for osteoarthritis. Cochrane Database Syst Rev. 2015.

  339. 371

    Singh M et al. Heated, humidified air for the common cold. Cochrane Database Syst Rev. 2017.

  340. 372

    Singh P et al. Taurine deficiency as a driver of aging. Science. 2023.

  341. 373

    Smith SM et al. Antibiotics for acute bronchitis. Cochrane Database Syst Rev. 2017.

  342. 374

    Spiegel K et al. Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med. 2004.

  343. 375

    Ständige Impfkommission (STIKO) am Robert Koch-Institut: Empfehlungen (Grippe, Pneumokokken, Pertussis).

  344. 376

    Ständige Impfkommission (STIKO) am Robert Koch-Institut: Empfehlungen zur Influenza-Impfung.

  345. 377

    Steuri R et al. Effectiveness of conservative interventions including exercise, manual therapy and medical management in adults with shoulder impingement: a systematic review and meta-analysis. Br J Sports Med. 2017.

  346. 378

    Stohs SJ. Safety and efficacy of shilajit (mumie, moomiyo). Phytother Res. 2014.

  347. 379

    Storer TW et al. Effects of Testosterone Supplementation for 3 Years on Muscle Performance and Physical Function in Older Men. J Clin Endocrinol Metab. 2017.

  348. 380

    Stranges S et al. Effects of long-term selenium supplementation on the incidence of type 2 diabetes: a randomized trial. Ann Intern Med. 2007.

  349. 381

    Suares NC, Ford AC. Systematic review: the effects of fibre in the management of chronic idiopathic constipation. Aliment Pharmacol Ther. 2011.

  350. 382

    Tacklind J et al.: Serenoa repens for benign prostatic hyperplasia. Cochrane Database Syst Rev, 2012.

  351. 383

    Tai V et al. Calcium intake and bone mineral density: systematic review and meta-analysis. BMJ. 2015.

  352. 384

    The correlation between selenium levels and autoimmune thyroid disease: a systematic review and meta-analysis. Ann Palliat Med. 2021.

  353. 385

    The efficacy of gluteal tendinopathy treatments: a systematic review. Clin Rehabil. 2025.

  354. 386

    The Myrtus communis L. solution versus ketoconazole shampoo in treatment of dandruff: a double-blind randomised clinical trial. J Pak Med Assoc. 2018.

  355. 387

    Thompson IM et al. Prevalence of prostate cancer among men with a PSA level ≤ 4.0 ng per milliliter. N Engl J Med. 2004.

  356. 388

    Tibaek S, Gard G et al. The effect of pelvic floor muscle training on sexual function in men with lower urinary tract symptoms. Top Stroke Rehabil. 2015.

  357. 389

    Timmer A et al. Pelargonium sidoides extract for treating acute respiratory tract infections. Cochrane Database Syst Rev. 2013.

  358. 390

    Traber MG. Vitamin E inadequacy in humans: causes and consequences. Adv Nutr. 2014.

  359. 391

    Trauer JM et al. Cognitive Behavioral Therapy for Chronic Insomnia: A Systematic Review and Meta-analysis. Ann Intern Med. 2015.

  360. 392

    Tzang CC et al. Insights into the cardiovascular benefits of taurine: a systematic review and meta-analysis. Nutr J. 2024.

  361. 393

    Vahlensieck W et al. Effects of pumpkin seed in men with lower urinary tract symptoms due to benign prostatic hyperplasia in the one-year, randomized, placebo-controlled GRANU study. Urol Int. 2015.

  362. 394

    Vaucher P et al. Effect of iron supplementation on fatigue in nonanemic menstruating women with low ferritin: a randomized controlled trial. CMAJ. 2012.

  363. 395

    Verma H, Garg R. Effect of magnesium supplementation on type 2 diabetes associated cardiovascular risk factors: a systematic review and meta-analysis. J Hum Nutr Diet. 2017.

  364. 396

    Vollset SE et al. Effects of folic acid supplementation on overall and site-specific cancer incidence during randomised trials: meta-analysis. Lancet. 2013.

  365. 397

    Volpe SL. Magnesium and the Athlete. Curr Sports Med Rep. 2015.

  366. 398

    von Luckner A, Riederer F. Magnesium in Migraine Prophylaxis — Is There an Evidence-Based Rationale? A Systematic Review. Headache. 2018.

  367. 399

    Wagenlehner FM et al. A pollen extract (Cernilton) in patients with inflammatory CP/CPPS: a phase 3 study. Eur Urol. 2009.

  368. 400

    Wagenlehner FM et al. NIH-CPSI symptom evaluation in multinational cohorts of patients with CP/CPPS. Eur Urol. 2013.

  369. 401

    Walker AF et al. Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study. Magnes Res. 2003.

  370. 402

    Walther A et al. Association of Testosterone Treatment With Alleviation of Depressive Symptoms in Men: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2019.

  371. 403

    Wang YH et al. Effects of aerobic exercise on inflammatory factors in healthy adults: a meta-analysis. Eur Rev Med Pharmacol Sci. 2022.

  372. 404

    Wang Z et al. Effects of Creatine Supplementation and Resistance Training on Muscle Strength Gains in Adults <50 Years of Age. Nutrients. 2024.

  373. 405

    Wang Z et al. The efficacy and safety of Curcuma longa extract and curcumin supplements on osteoarthritis: a systematic review and meta-analysis. Biosci Rep. 2021.

  374. 406

    Watanabe F et al. Vitamin B12-containing plant food sources for vegetarians. Nutrients. 2014.

  375. 407

    Wei ZH et al. Time- and dose-dependent effect of psyllium on serum lipids in mild-to-moderate hypercholesterolemia: a meta-analysis of controlled clinical trials. Eur J Clin Nutr. 2009.

  376. 408

    Wider B et al. Artichoke leaf extract for treating hypercholesterolaemia. Cochrane Database Syst Rev. 2013.

  377. 409

    Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021.

  378. 410

    Williams G et al. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2023.

  379. 411

    Williams G et al. Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev. 2023.

  380. 412

    Williams JL et al. L-theanine, unique amino acid of tea, and its metabolism, health effects, and safety. Crit Rev Food Sci Nutr. 2017.

  381. 413

    World Health Organization (WHO): Guideline: Potassium intake for adults and children. 2012 (mindestens 3.510 mg/Tag für Erwachsene).

  382. 414

    Wu H et al. The association of dietary spermidine with all-cause mortality and CVD mortality: NHANES 2003 to 2014. Front Public Health. 2022.

  383. 415

    Xiao GM et al. Berberine and berberrubine promote the expression of CYP3A4 via enhancing the binding of nuclear receptor PXR. BMC Pharmacol Toxicol. 2025.

  384. 416

    Xu C et al. The effects of creatine supplementation on cognitive function in adults: a systematic review and meta-analysis. Front Nutr. 2024.

  385. 417

    Yadav D et al. Safety and Efficacy of TruBlk™ Shilajit Resin Supplementation on Physical Performance and Blood Biomarkers in Healthy Adults. Cureus. 2026.

  386. 418

    Yang JM, Ye H et al. Effect of pelvic floor muscle training on urinary incontinence after radical prostatectomy: a meta-analysis. Clin Rehabil. 2023.

  387. 419

    Yi L et al. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults. Geroscience. 2023.

  388. 420

    Yoshino M et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021.

  389. 421

    Zafar MI et al. Low-glycemic index diets as an intervention for diabetes: a systematic review and meta-analysis. Am J Clin Nutr. 2019.

  390. 422

    Zeng L et al. Efficacy and safety of curcumin therapy for knee osteoarthritis: a Bayesian network meta-analysis. J Ethnopharmacol. 2024.

  391. 423

    Zhang Y et al. Association of magnesium intake with sleep duration and sleep quality: findings from the CARDIA study. Sleep. 2022.

  392. 424

    Zhang Y et al. Can Magnesium Enhance Exercise Performance? Nutrients. 2017.

  393. 425

    Zhang Y et al. Effect of Low-Dose Vitamin K2 Supplementation on Bone Mineral Density in Middle-Aged and Elderly Chinese: A Randomized Controlled Study. Calcif Tissue Int. 2020.

  394. 426

    Zhao H et al. Assessment of Urolithin A effects on muscle endurance, strength, inflammation, oxidative stress, and protein metabolism in male athletes with resistance training. J Int Soc Sports Nutr. 2024.

Ein Link zu PubMed ist kein Beleg dafür, dass eine Studie unumstritten ist. Wir bevorzugen systematische Übersichten, Metaanalysen und kontrollierte Studien und ordnen die Aussagekraft im jeweiligen Artikel ein.